Strides Pharma Science Secures USFDA Approval for Celecoxib Capsules, Expands U.S. Portfolio

Unknown Apr 02, 2026 1,200 Views

Strides Pharma Science Ltd has received approval from the U.S. Food and Drug Administration (USFDA) for its Celecoxib Capsules, marking a significant addition to the company’s growing U.S. generics portfolio. The approved product is a generic version of Celecoxib, a widely prescribed nonste...

Stay Ahead – Explore Now! Bullion Markets Brace for Central Bank Decisions and U.S.-Iran Peace Talks